VOLUNTARY DISSOLUTION - LIQUIDATION

QUALIBLOOD

Export PDF

Company — Voluntary dissolution - liquidation.

Financial year 2024 · Closed on 31/12/2024

Net result-560,1 k €-20,7 %over 1 year

Gross margin-251,4 k €-546,2 %over 1 year

Equity847,1 k €+354,2 %over 1 year

Workforce6,6 ETP+8,2 %over 1 year

Identity

Source · BCE/KBO

QUALIBLOOD is a Public limited company incorporated in 2017. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Liège. It employs on average 6,6 ETP workers (FTE).

Legal situation: Voluntary dissolution - liquidation
BCE/KBO no. / VAT: BE 0684.698.353
Incorporation: 15/11/2017
Legal form: Public limited company
Registered office: Rue Louvrex 55-57
4000 Liège · WallonieSee on map
Contributed capital: 110 000,00 €
Latest accounts: 31/12/2024
Average workforce: 6,6 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology

Joint committees (2)

330
33004

Contacts

2 public details availableLog in to view

Signals

Solid equityGood liquidityHealthy social debts

Financials

Source · NBB, 8 filings

Trend over 7 financial years

	2024		2023		2022		2021		2020
Income statement
Gross margin	-251,4 k €	-546%	56,3 k €	-87.0%	433,6 k €	-54.8%	958,3 k €	+103%	472,7 k €
EBITDA	-651,2 k €	-78.4%	-364,9 k €	-1572%	-21,8 k €	-104%	589,9 k €	+143%	243,1 k €
Operating result	-730,9 k €	-67.8%	-435,7 k €	-238%	-128,9 k €	-125%	511 k €	+149%	204,8 k €
Net result	-560,1 k €	-20.7%	-464 k €	-251%	-132 k €	-129%	455,5 k €	+125%	202,3 k €
Balance sheet
Equity	847,1 k €	+354%	186,5 k €	-71.3%	650,5 k €	-16.9%	782,6 k €	+131%	338,1 k €
Total assets	2,6 M €	+137%	1,1 M €	+18.5%	934,4 k €	-28.8%	1,3 M €	-33.9%	2 M €
Cash	199,6 k €	-52.3%	418,1 k €	+381%	87 k €	-88.4%	750,6 k €	-39.8%	1,2 M €
Debts	1,4 M €	+49.7%	916,1 k €	+227%	279,9 k €	-45.9%	517,3 k €	-64.7%	1,5 M €
Other
Workforce	6,6 ETP	+8.2%	6,1 ETP	-12.9%	7,0 ETP	+2.9%	6,8 ETP	+38.8%	4,9 ETP

Board of directors

Source · NBB, accounts to 31/12/2024

6 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Bernard MASEREEL	Director14/11/2017 → 26/03/2030Chairman of the board of directors14/11/2017 → 2021 accountsended
CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR0641.733.885Represented by de Saint-Hubert Marie	Director14/11/2017 → 26/03/2030Mandate2019 accountsended
Conseils, Gestion, Organisation0427.607.573Represented by Delaunois PHILIPPE	Director14/11/2017 → 26/03/2030
Jean-Michel FOIDART	Director14/11/2023 → 26/03/2030
NAMUR INVEST0456.316.803Represented by OGER Maxime	Director14/11/2023 → 26/03/2030
NOSHAQ PARTNERS0808.219.836Represented by Sabatel HÉLÈNE	Director26/03/2024 → 26/03/2030

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
UNAMUR VENTURE0553.941.561Represented by Lievens PIERRE-YVES	Director14/11/2018 → 2023 accounts
PHARMXPERTISE0742.556.675Represented by Jonathan DOUXFILS	Director29/12/2020 → 2020 accounts
BIOPHA0860.247.567Represented by BERNARD MASEREEL	Chairman of the board of directors14/11/2017 → 2018 accounts

Other companies at this address

Rue Louvrex 55-57 4000 Liège

Company	CBE no.
Agence locale pour l'Emploi de Villers-le-Bouillet● Liquidation	0455.591.479
BCH HILL● Liquidation	0700.301.594
CR AVOCAT Société d’avocats● Active	0688.854.507
ERGOCONSULT● Liquidation	0651.772.001
EXIMPA● Liquidation	0414.865.832
FHL AVOCAT● Active	0789.713.919
GROUPE MOSAL● Active	0715.620.369
HEDERA 22● Liquidation	0630.923.236
IMMOSAL● Active	0707.919.559
Isosystems● Liquidation	0873.988.014
LASERFLASH● Liquidation	0447.621.346
LAURENT SCHREIBER AVOCAT● Active	1011.066.830
LM GESTION● Active	0430.928.834
MG Legal société d'avocats● Active	0556.751.987
MOSAL● Active	0827.814.133
PDC line Pharma● Liquidation	0657.842.221
SPARX INDUSTRIES● Liquidation	0476.423.022
THERATOPIX PHARMA● Liquidation	0738.446.251
VINCENT LAMBERTS AVOCAT● Active	0686.711.005
VM Avocat● Active	0785.439.187

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/05/2025	09/07/2024	15/06/2023	23/08/2022	06/05/2021	17/04/2020
General meeting	27/03/2025	28/03/2024	23/03/2023	24/03/2022	25/03/2021	26/03/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 8 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	27/03/2025	07/05/2025	French	PDF
Abridged model	31/12/2023	28/03/2024	09/07/2024	French	PDF
Abridged model	31/12/2022	23/03/2023	15/06/2023	French	PDF
Abridged model	31/12/2021	24/03/2022	23/08/2022	French	PDF
Abridged model	31/12/2020	25/03/2021	06/05/2021	French	PDF
Abridged model	31/12/2019	26/03/2020	17/04/2020	French	PDF
Abridged modelCorrection	31/12/2018	28/03/2019	25/06/2019	French	PDF
Abridged model	31/12/2018	28/03/2019	29/04/2019	French	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

6 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Bernard MASEREEL	Director14/11/2017 → 26/03/2030Chairman of the board of directors14/11/2017 → 2021 accountsended
CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR0641.733.885Represented by de Saint-Hubert Marie	Director14/11/2017 → 26/03/2030Mandate2019 accountsended
Conseils, Gestion, Organisation0427.607.573Represented by Delaunois PHILIPPE	Director14/11/2017 → 26/03/2030
Jean-Michel FOIDART	Director14/11/2023 → 26/03/2030
NAMUR INVEST0456.316.803Represented by OGER Maxime	Director14/11/2023 → 26/03/2030
NOSHAQ PARTNERS0808.219.836Represented by Sabatel HÉLÈNE	Director26/03/2024 → 26/03/2030

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
UNAMUR VENTURE0553.941.561Represented by Lievens PIERRE-YVES	Director14/11/2018 → 2023 accounts
PHARMXPERTISE0742.556.675Represented by Jonathan DOUXFILS	Director29/12/2020 → 2020 accounts
BIOPHA0860.247.567Represented by BERNARD MASEREEL	Chairman of the board of directors14/11/2017 → 2018 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Registered office01/04/2026
SIEGE SOCIAL
PDF
Court decision04/12/2025
RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
PDF
Mandates16/04/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL - DIVERS - DEMISSIONS, NOMINATIONS
PDF
Mandates13/12/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates03/05/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates31/12/2020
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
PDF
Other17/11/2017
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings7 filings

Mandates

Conseils, Gestion, Organisation

NAMUR INVEST

CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR

NOSHAQ PARTNERS

Jean-Michel FOIDART

Bernard MASEREEL

UNAMUR VENTURE

PHARMXPERTISE

Université de Namur

NAMUR INVEST PREFACE

BIOPHA

DAMIEN GHELDOF

Show the other mandate

20172018201920202021202220232024202520262027202820292030

QUALIBLOOD

Boulevard Patience & Beaujonc 3, 4000 LiègeRue du Séminaire 20 bte A, 5000 Namur

Director

DirectorChairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Louvrex 55-57, 4000 LiègeCurrent		CBE
Boulevard Patience & Beaujonc 3, 4000 Liège	accounts 2023 → 2024	Accounts 2024 · 2025-00089739
Rue du Séminaire 20 bte A, 5000 Namur	accounts 2021 → 2022	Accounts 2022 · 2023-00132892

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
QUALIBLOODCurrent	accounts 2018 → 2024	Accounts 2024 · 2025-00089739

Events

2024
Annual accounts 2024-560,1 k €↓
2023
Annual accounts 2023-464 k €↓
2022
Annual accounts 2022-132 k €↓
2021
Annual accounts 2021455,5 k €↑
2020
Annual accounts 2020202,3 k €↑
2019
Annual accounts 201923,5 k €↑
2018
Annual accounts 20182,3 k €
15/11/2017
IncorporationPublic limited company

QUALIBLOOD

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events